Biocon Appoints Mukesh Rathi as Chief Technology Officer - Designate
#Leadership #DigitalTransformation #Technology #LeadershipUpdates #LifeSciences #Biocon #DigitalInnovation #PharmaTech
Nov 2026 : Biocon Limited has recently appointed Mukesh Rathi as its Chief Technology Officer-Designate, signaling a bold step forward in its evolution into a fully integrated global healthcare power. Rathi will assume full responsibility as Chief Technology Officer on January 1, 2027, spearheading the company’s enterprise-wide digital strategy, AI roadmap, and technology infrastructure.
With over 27 years of experience, Rathi’s appointment comes at a pivotal juncture as Biocon deepens its reliance on data science and advanced automation across R&D, manufacturing, supply chain, and global market access.
Most recently, Rathi served as President and Group Chief Digital Officer at Hinduja Group. Before that, he spent over 11 years at Dr. Reddy’s Laboratories in key executive roles - most notably as Global Chief Digital and Information Officer - where he spearheaded India’s first Digital Lighthouse pharma facility and drove an enterprise-wide SAP S/4HANA cloud migration. His foundational leadership and consulting expertise were built through earlier roles at Hewlett Packard (HP Enterprise Services), Genpact, SAP India, Hindustan Unilever Ltd (HUL), and Tata Technologies.
Rathi holds a B.Tech in Industrial Engineering from IIT Kharagpur, a PGDM in Finance, Systems, and Operations from IIM Lucknow, and completed executive education in digital platforms at Harvard Business School alongside executive training at IMD.
NEWSLETTER
TRENDING ON PRO MFG
MORE FROM THE SECTION
